Syantra
A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
About
Syantra is a precision biotechnology company focused on revolutionizing cancer detection and treatment. Their proprietary Onco-ID™ platform utilizes a blood-based liquid biopsy to detect early signs of cancer by analyzing shifts in the body's immune system and physiological responses, rather than directly looking for cancer cells. This approach aims to enable earlier diagnosis and more effective interventions.
Key facts
- Website
- syantra.ca
- Headquarters
- Calgary, Canada
- Founded
- 2016
- Employees
- 14
- Total funding
- $4M (Series A-1)
- Valuation
- Private
- Business model
- B2B
- Tags
- BiotechMedTechHealthTechGenomicsDrug Discovery
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Sept 2024 | Series A-1 | $4M | - |
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
Frequently asked
How much funding has Syantra raised?
Syantra has raised a total of $4M in funding. The most recent round on record is Series A-1.
How many employees does Syantra have?
Syantra has approximately 14 people on record.